Recorded live at the 4th BioCeuticals Research Symposium, Andrew talked with integrative cardiologist Dr Mark Houston about the changes he has witnessed in the management of cardiovascular disease. Dr Houston covers the relevance of patient genetics in understanding the progression of disease, as well as the modifiable risk factors and key methods of assessment based on his clinical experience. This insightful discussion shows there is a paradigm shift emerging in the understanding of cardiovascular disease.
